Skip to main content
. 2023 Jul 25;11:1080700. doi: 10.3389/fpubh.2023.1080700

Table 4.

Ebola vaccine concerns at the time of vaccination among health care workers (N = 416), North Kivu, Democratic Republic of the Congo, 2021.

n %, [95% CI]
Did you have concerns about the vaccine when you received it? N = 416
Yes 201 48.3 [45.7–51.0]
No 215 51.7 [49.0–54.3]
If yes, what concerns did you have? N = 201*
It may cause Ebola virus disease 59 29.4 [26.4–32.5]
It may cause death 97 48.3 [44.6–52.0]
It may cause side effects like muscle aches and body pain. 132 65.7 [61.4–69.7]
It may cause infertility or sexual/weakness 67 33.3 [29.4–37.4]
It cannot prevent Ebola 36 17.9 [14.8–21.5]
Lack of trust in vaccine manufacturer 26 12.9 [10.7–15.6]
Lack of trust in the process used to make the vaccine 9 4.5 [3.3–6.0]
Lack of trust in the team offering the vaccine 7 3.5 [2.2–5.5]
Lack of trust in the health system 2 1.0 [0.5–1.9]
*

Participants could indicate multiple responses.